TY - JOUR A1 - Liu, Han A1 - Chen, Chunhai A1 - Gao, Zexia A1 - Min, Jiumeng A1 - Gu, Yongming A1 - Jian, Jianbo A1 - Jiang, Xiewu A1 - Cai, Huimin A1 - Ebersberger, Ingo A1 - Xu, Meng A1 - Zhang, Xinhui A1 - Chen, Jianwei A1 - Luo, Wei A1 - Chen, Boxiang A1 - Chen, Junhui A1 - Liu, Hong A1 - Li, Jiang A1 - Lai, Ruifang A1 - Bai, Mingzhou A1 - Wei, Jin A1 - Yi, Shaokui A1 - Wang, Huanling A1 - Cao, Xiaojuan A1 - Zhou, Xiaoyun A1 - Zhao, Yuhua A1 - Wei, Kaijian A1 - Yang, Ruibin A1 - Liu, Bingnan A1 - Zhao, Shancen A1 - Fang, Xiaodong A1 - Schartl, Manfred A1 - Qian, Xueqiao A1 - Wang, Weimin T1 - The draft genome of blunt snout bream (Megalobrama amblycephala) reveals the development of intermuscular bone and adaptation to herbivorous diet JF - GigaScience N2 - The blunt snout bream Megalobrama amblycephala is the economically most important cyprinid fish species. As an herbivore, it can be grown by eco-friendly and resource-conserving aquaculture. However, the large number of intermuscular bones in the trunk musculature is adverse to fish meat processing and consumption. As a first towards optimizing this aquatic livestock, we present a 1.116-Gb draft genome of M. amblycephala, with 779.54 Mb anchored on 24 linkage groups. Integrating spatiotemporal transcriptome analyses, we show that intermuscular bone is formed in the more basal teleosts by intramembranous ossification and may be involved in muscle contractibility and coordinating cellular events. Comparative analysis revealed that olfactory receptor genes, especially of the beta type, underwent an extensive expansion in herbivorous cyprinids, whereas the gene for the umami receptor T1R1 was specifically lost in M. amblycephala. The composition of gut microflora, which contributes to the herbivorous adaptation of M. amblycephala, was found to be similar to that of other herbivores. As a valuable resource for the improvement of M. amblycephala livestock, the draft genome sequence offers new insights into the development of intermuscular bone and herbivorous adaptation. KW - Megalobrama amblycephala KW - whole genome KW - herbivorous diet KW - intermuscular bone KW - transcriptome KW - gut microflora Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-170844 VL - 6 IS - 7 ER - TY - JOUR A1 - Lindgreen, Stinus A1 - Umu, Sinan Uğur A1 - Lai, Alicia Sook-Wei A1 - Eldai, Hisham A1 - Liu, Wenting A1 - McGimpsey, Stephanie A1 - Wheeler, Nicole E. A1 - Biggs, Patrick J. A1 - Thomson, Nick R. A1 - Barquist, Lars A1 - Poole, Anthony M. A1 - Gardner, Paul P. T1 - Robust Identification of Noncoding RNA from Transcriptomes Requires Phylogenetically-Informed Sampling JF - PLOS Computational Biology N2 - Noncoding RNAs are integral to a wide range of biological processes, including translation, gene regulation, host-pathogen interactions and environmental sensing. While genomics is now a mature field, our capacity to identify noncoding RNA elements in bacterial and archaeal genomes is hampered by the difficulty of de novo identification. The emergence of new technologies for characterizing transcriptome outputs, notably RNA-seq, are improving noncoding RNA identification and expression quantification. However, a major challenge is to robustly distinguish functional outputs from transcriptional noise. To establish whether annotation of existing transcriptome data has effectively captured all functional outputs, we analysed over 400 publicly available RNA-seq datasets spanning 37 different Archaea and Bacteria. Using comparative tools, we identify close to a thousand highly-expressed candidate noncoding RNAs. However, our analyses reveal that capacity to identify noncoding RNA outputs is strongly dependent on phylogenetic sampling. Surprisingly, and in stark contrast to protein-coding genes, the phylogenetic window for effective use of comparative methods is perversely narrow: aggregating public datasets only produced one phylogenetic cluster where these tools could be used to robustly separate unannotated noncoding RNAs from a null hypothesis of transcriptional noise. Our results show that for the full potential of transcriptomics data to be realized, a change in experimental design is paramount: effective transcriptomics requires phylogeny-aware sampling. KW - protein families database KW - small nucleolar RNAs KW - bacterial genomes KW - comparative genomics KW - dark-matter KW - homology search KW - archaea KW - sequence KW - alignment KW - insights Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-115259 VL - 10 IS - 10 ER - TY - JOUR A1 - Estes, Chris A1 - Anstee, Quentin M. A1 - Arias-Loste, Maria Teresa A1 - Bantel, Heike A1 - Bellentani, Stefano A1 - Caballeria, Joan A1 - Colombo, Massimo A1 - Craxi, Antonio A1 - Crespo, Javier A1 - Day, Christopher P. A1 - Eguchi, Yuichiro A1 - Geier, Andreas A1 - Kondili, Loreta A. A1 - Kroy, Daniela C. A1 - Lazarus, Jeffrey V. A1 - Loomba, Rohit A1 - Manns, Michael P. A1 - Marchesini, Giulio A1 - Nakajima, Atsushi A1 - Negro, Francesco A1 - Petta, Salvatore A1 - Ratziu, Vlad A1 - Romero-Gomez, Manuel A1 - Sanyal, Arun A1 - Schattenberg, Jörn M. A1 - Tacke, Frank A1 - Tanaka, Junko A1 - Trautwein, Christian A1 - Wei, Lai A1 - Zeuzem, Stefan A1 - Ravazi, Homie T1 - Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 JF - Journal of Hepatology N2 - Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease burden using currently available data. Methods A model was used to estimate NAFLD and NASH disease progression in eight countries based on data for adult prevalence of obesity and type 2 diabetes mellitus (DM). Published estimates and expert consensus were used to build and validate the model projections. Results If obesity and DM level off in the future, we project a modest growth in total NAFLD cases (0–30%), between 2016–2030, with the highest growth in China as a result of urbanization and the lowest growth in Japan as a result of a shrinking population. However, at the same time, NASH prevalence will increase 15–56%, while liver mortality and advanced liver disease will more than double as a result of an aging/increasing population. Conclusions NAFLD and NASH represent a large and growing public health problem and efforts to understand this epidemic and to mitigate the disease burden are needed. If obesity and DM continue to increase at current and historical rates, both NAFLD and NASH prevalence are expected to increase. Since both are reversible, public health campaigns to increase awareness and diagnosis, and to promote diet and exercise can help manage the growth in future disease burden. Lay summary Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis can lead to advanced liver disease. Both conditions are becoming increasingly prevalent as the epidemics of obesity and diabetes continue to increase. A mathematical model was built to understand how the disease burden associated with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis will change over time. Results suggest increasing cases of advanced liver disease and liver-related mortality in the coming years. KW - burden of disease KW - cardiovascular disease KW - health care resource utilization KW - metabolic syndrome KW - NAFLD KW - NASH KW - cirrhosis KW - HCC KW - diabetes mellitus KW - obesity Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227286 VL - 69 ER -